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Abstract
The spray-dried Vernonia amygdalina water extract was evaluated for antidiabetic effect using 
normoglycaemic, glucose induced hyperglycaemic and streptozotocin induced diabetic mice. 
This effect was compared with an oral dose of Momordica charantia. Besides, acute toxicity of 
the extract was also evaluated at concentration 2000 and 5000 mg/kg body weight. The extract 
was able to reduce blood glucose level in glucose and streptozotocin induced hyperglycaemic 
mice without causing hypoglycemic effect on fasting normoglycaemic mice. Moreover, mice 
appeared to be normal and no mortality was observed in the acute toxicity study after treated with 
up to 5000mg/kg of extract. These results indicated that the spray-dried Vernonia amygdalina 
water extract was a potential antidiabetic agent which does not induce hypoglycemic and acute 
toxicity on normal subject. 
Introduction
Diabetes mellitus is one of the main causes 
of serious maladies in the 21st century. The world 
population of diabetic mellitus in year 2008 was 
approximate 150 million and the population of this 
pandemic was expected to double by year 2025 (Tan 
et al., 2008). Malaysia contained the fourth highest 
number of diabetic patients in Asia (approximate 
800,000 in year 2007 and expected to reach 1.3 
million in year 2010 (Lee and Loh, 2010). Type 2 
diabetic, normally associated with obesity and was 
commonly accepted to be induced by high calorie 
diet, less exercise following by insulin resistance. 
This type of diabetic is the major contributor of 
diabetic incident as compared to genetically inherited 
type 1 diabetic (Viollet et al., 2009). Vernonia 
amygdalina (Family: Compositae) is a soft wooded 
shrub that traditionally used to treat diabetes. Studies 
have shown that various extracts of V. amygdalina 
have possessed hypoglycemic effect on alloxan 
monohydrate and streptozotocin induced diabetic 
animals (Nwanjo, 2005; Igbakin and Oloyede, 
2009). However, the hypoglycemic effect of spray-
dried water extract on diet induced diabetes is still 
remaining unknown. Thus, this study is to verify the 
preservation on antidiabetic effect of spray-dried 
water extract especially on diet induced diabetes.  
Materials and Methods 
Reagents
Streptozotocin (STZ), Glucose and Glucose 
(GO) assay kit were purchased from Sigma (USA). 
Momordica charantia was purchase from INS 
(Malaysia). High fat diet contained about 18.3% 
carbohydrate, 30% of lipid, 20% protein and 31.7% 
of other ingredients. 
Plant material
Leaves of V. amygdalina were collected on the 
herbal plantation in Kuala Selangor, Malaysia on 
June 2008 and were identified by science officer 
Lim Chung Lu (Kepong, Selangor) from Forestry 
Division, Forest Research Institute Malaysia 
(FRIM). The voucher number of V. amygdalina is 
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in shade and finely powdered. The leaf extract was 
prepared by keeping 1g of leaf powders soaked in 80 
mL of deionised water (60oC) for 2 hours. Then, the 
extract was filtered with Whatman filter paper no 1 
(Millipore, Malaysia), mix with maltodextrin (ratio 
1:1) and subjected to spray dry at an air pressure of 1.4 
bar and operating temperature of 145ºC (yield 25%, 
w/w). The spray dried powder was store at 40C.   
Animals
A total 30 male of Imprinting Control Region 
(ICR) mice, 5-8 weeks old, weight between 20-25 
g were used in all experiments. The animals were 
purchased from the Animal House, University Putra 
Malaysia. The animals were housed under standard 
conditions at room temperature and fed with standard 
pellets and tap water. This work had been approved 
by the Animal Care and Use Committee, University 
Putra Malaysia (UPM). 
Acute toxicity tests
A separate experiment was carried out to study 
the acute toxicity of spray-dried V. amgydalina 
water extract on mice (8 weeks old). Normal healthy 
male mice was randomly divided into three group 
which feed with the vehicle-treated “control” group 
(Phosphate buffer saline) and two concentration of 
extract-treated “experimental” groups, totally making 
up to 3 groups of 10 animals per each group. Extract 
(2000 and 5000 mg/kg body weight) and vehicle 
(PBS) control was separately administered orally to 
the mice. All the mice were allowed access to food 
and water. Behaviour changes and mortality were 
observed and recorded over a period of 24 hours. All 
animal was further incubated until day 14.  
Hypoglycemic and oral glucose tolerance test
Diabetic mice were induced by either 
intraperitoneal injection of streptozotocin (STZ, 200 
mg/kg body weight) or high fat diet on the mice (initial 
6 weeks old and fed with high fat diet that contained 
18.3% carbohydrate, 30% lipid, 20% protein and 
31.7% of other ingredients (Liu et al., 2010) for 
1 month). Two weeks later, blood was collected 
through lateral tail vein and the blood glucose level 
was monitored. Only mice with blood glucose over 
200 mg/dL were considered diabetic and selected for 
the glucose tolerance test. 
In the hypoglycemic and glucose tolerance test, 
mice were randomly divided into 12 groups with each 
contain 8 animals. Groups 1 to 4 contained all normal 
mice (hypoglycemic study), Group 5 to 8 with high 
fat induced diabetic mice and Group 9 to 12 were 
STZ induced mice. Mice were fasted for 18 hours 
prior the test and blood glucose level at time zero 
was determined prior to the administration of vehicle 
(PBS) control or extract treatment. Animals in group 
1, 5 and 9 were given 1X PBS (0.1mL). For group 
2, 6 and 10, Momordica charantia (INS, Malaysia) 
(24µIU/kg/0.1mL of plant insulin which was detected 
through serum radiation immunoassay) was given as 
positive control. Group 3, 7 and 11 and group 4, 8 
and 12 were given spray-dried V. amygdalina water 
extract at 10 and 50 mg/kg/0.1mL, respectively. 
Animals in group 1 to 4 were orally given vehicle or 
extract at time zero while animals in group 5 to 12 
were orally given vehicle or extract together with 1g/
kg body weight of glucose solution after the blood 
glucose measurement at time zero. Blood glucose 
for animals in all groups was further monitor at 30, 
60, 90 and 180 minutes after the vehicle and extract 
administration. Blood samples were collected from 
the vein of the mice and the blood glucose level was 
tested with GO assay kit (Sigma, USA) according to 
the manufacturer’s protocol. The glucose level was 
expressed in percentage (%) change from the initial 
glycaemia using the following formula: 
                                              
% glycaemia change =         Gx - Go   X  100
                                                   Go
Go is the glycaemia value at time zero after overnight 
fasting; Gx is the glycaemia value at x minutes after 
vehicle or extract administration. 
Statistical analysis
Experimental results are expressed as mean ± 
SD in triplicate. The data were analysed by ANOVA 
(p<0.05) and means separated by Duncan’s multiple 
range tests (by SPSS version 13 software). 
Results
Acute toxicity studies revealed that non-toxic 
nature of the spray-dried V. amgydalina water extract 
on normal healthy male mice even up to 5000 mg/
kg body weight. No mortality was observed in 
the extract-treated mice and behaviour of all the 
experimental groups appeared the same and normal 
up to day 14. 
The hypoglycaemic effect on fasting normal 
mice is shown in Figure 1. Fasting blood glucose 
of mice treated with PBS fluctuated during 180 
minute monitoring period. Both M. charantia and V. 
amygdalina extract caused a significant raise of blood 
glucose at 30 minute time point of the test. After that, 
the blood glucose level of all extracts treated mice 
steadily revert back to initial glucose level. Increase 
of blood glucose of mice treated with 10 mg/kg V. 
amygdalina was significantly less when compared 
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with mice treated with 50 mg/kg V. amygdalina and 
M. charantia.  
Glucose induced less blood sugar raised on 
V. amygdalina treated diet induced diabetic mice 
compared to M. charantia treated and control 
diabetic mice (Figure 2). The peak blood glucose 
concentration then fell to the initial blood glucose 
much faster on mice treated with V. amygdalina and 
remain lower then the initial blood glucose during the 
180 minute testing period.    
Figure 3 showed that both V. amygdalina and M. 
charantia significantly maintained the blood glucose 
level of STZ induced diabetic mice than untreated 
group (Group 9). Blood glucose of untreated mice 
rose from initial level to the peak value at 30 minutes 
time point and steady at 40% rose after 120 minute 
of oral glucose tolerance test. None of the groups 
were observed with drop of glucose level lower than 
initial.   
Discussion 
In this study, V. amgydalina did not induce any 
mortality up to 5g/kg b.w. on mice. Traditionally, 
V. amygdalina was consumed as vegetable as a 
source of protein in Africa (Ndaeyo, 2007). The 
acute toxicology study has confirmed that it can be 
classified as safe to be consumed.
Previous study has showed that V. amygdalina 
aqueous extract was able to induced hypoglycemic 
effect on non-diabetic rat (Taiwo et al., 2009). 
However, in this study, both V. amygdalina and M. 
charantia were observed with raised glucose level in 
fasting normal mice. This may be due to the present of 
maltodextrin which was added as carrier during spray 
drying process of V. amygdalina. For M. charantia, 
maltodextrin is a common bulking agent in preparing 
supplement capsule. Thus, it is observed that higher 
concentration of V. amygdalina extract induced 
higher level of glucose rise compared to untreated 
normal mice. Diabetes mellitus is a pathologic 
condition cause by severe metabolic imbalances 
and non-physiologic changes due to oxidative stress 
in pancreas islets which was created by persistent 
and chronic hyperglycemia and thus damages the 
pancreatic β cells (Arulselvan and Subramanian, 
2007). Unlike some of the anti-diabetic drug, such 
as tolbutamide, which reduces blood glucose through 
increasing insulin secretion and sensitivity, V. 
amydalina and M. charantia was able to reduce blood 
glucose level on both diet induced and STZ induced 
diabetic mice. Sesquiterpene lactones and the bitter 
principles of the extract were proposed to have 
contributed in stimulation of insulin sensitisation that 
caused hyperglycemic effect (Osinubi, 2007). STZ 
caused cytotoxic effect on pancreatic β cells which 
further induced insulin dependent diabetes. This 
study also showed that the secondary metabolites in 
V. amygdalina may also replace insulin which cannot 
being produced in STZ treated mice to metabolise 
glucose. Moreover, the sesquiterpene lactones, bitter 
principles and phenolic compounds in V. amygdalina 
were also believed to initiate the beta cell regeneration 
through their antioxidant activity. Thus, V. amygdalina 
was suitable to be used in managing both type I and 
type II diabetes mellitus.   
Conclusion
 
This study has suggested that spray-dried 
V. amygdalina aqueous extract was suitable for 
managing diabetes. Furthermore, it was also safe to 
be consumed by normal subject without inducing 
severe hypoglycemic and toxic side effect. Further 
Figure 1. Glycaemic effect of V. amygdalina and M. charantia in 
fasting normal mice
Figure 2. Effect of V. amygdalina and M. charantia on oral glucose 
tolerance in fasting diet induced diabetic mice
Figure 3. Effect of V. amygdalina and M. charantia on oral glucose 
tolerance in fasting STZ induced diabetic mice
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study on long term administration on type I and type 
II diabetes management should be carried out in 
future. 
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